Can-Fite Biopharma Other Current Liabilities

As of the most recent data (June 2026), CANF shows a other current liabilities of $1.5M. That compares with $510K in the prior-year period — up 195.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CANF's other current liabilities is now $1.5M (was $510K) — a 195.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Can-Fite Biopharma is outperforming or lagging.

Tracking CANF's other current liabilities over time shows whether Can-Fite Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5M That compares with $510K in the prior-year period — up 195.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Can-Fite Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $1.5M) with ownership activity and broader fundamentals.

Can-Fite Biopharma's other current liabilities is $1.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.